| Structure | Chemical Name | CAS | MF |
|
HYPOXISCOLCHICIFOLIA
|
|
|
|
|
HYPOXISHEMEROCALLIDEA
|
|
|
|
|
Hypoxia Inducible Factor 1 (HIF-1, MOP1) Not tested by USB. Available N/C for customer testing
|
|
|
|
|
Hypoxanthine, Disodium Salt N/A
|
|
|
|
hypoxanthinedisodiummin.
|
|
C5H5N5Na2O
|
|
Hypoxanthine monosodium
|
45738-97-4
|
C5H4N4NaO
|
|
HYPOXANTHINE-1-OXIDE
|
5167-14-6
|
C5H4N4O2
|
|
HYPOXANTHINE 9-B-D-ARABINOFURANOSIDE
|
|
C10H12N4O6
|
|
|
Hypoxia Inducible Factor 3a (HIF-3a)
|
|
|
|
|
Hypoxia Inducible Factor 1 alpha (HIF-1a)
|
|
|
|
|
Hypoxia Inducible Factor 1, Control Peptide (HIF-1, MOP1) (BSA)
|
|
|
|
|
Hypoxia Inducible Factor 1a (HIF-1a)
|
|
|
|
|
HYPOXANTHINE, [13C(U)]-, MORPURE HPLC PURIFIED, DELIVERED >= 98% PURE WITH HPLC UV CHROMATOGRAM
|
|
|
|
|
hypoxoside
|
83643-94-1
|
|
|
|
Hypoxanthine Phosphoribosyltransferase
|
|
|
|
|
Hypoxanthines
|
|
|
|
|
hypoxanthine-guanine-xanthine phosphoribosyltransferase
|
|
|
|
|
hypoxia-associated factor
|
|
|
|
|
hypoxysordarin
|
|
|
|
|
HYPOXANTHINE, [2,8-3H]- 10-30 CI(0.37-1.11 TBQ)/MMOL, MORPURE HPLC PURIFIED, DELIVERED >= 97% PURE WITH HPLC RADIOCHROMATOGRAM
|
|
|
|
|
Hypoxia Inducible Factor 2a (HIF-2a, EPAS1)
|
|
|
|
|
Hypoxia Inducible Factor 1b (HIF-1b, ARNT, Aryl hydrocarbon Receptor Nuclear Translocator)
|
|
|
|
|
Hypoxia Inducible Factor 1 beta (HIF-1b, ARNT, Aryl hydrocarbon Receptor Nuclear Translocator)
|
|
|
|
|
HYPOXANTHINE, [14C(U)]- 230-280 MCI(8.51-10.36 GBQ)/MMOL, MORPURE HPLC PURIFIED, DELIVERED >= 98% PURE WITH HPLC RADIOCHROMATOGRAM
|
|
|
|
|
HYPOXANTHINE DISODIUM 98% MIN.
|
|
|
|
|
HYPOXANTHINE, [8-14C]- 50-60 MCI(1.85-2.22 GBQ)/MMOL, MORPURE HPLC PURIFIED, DELIVERED >= 98% PURE WITH HPLC RADIOCHROMATOGRAM
|
|
|
|
|
Hypoxia Inducible Factor 1b (HIF-1b, ARNT, Aryl hydrocarbon Receptor Nuclear Translocator) (BSA & Azide Free)
|
|
|
|
HYPOXANTHINE, MONOSODIUM SALT
|
|
C5H3N4NaO
|
|
|
HYPOXANTHINE-[2,8-3H]
|
33917-71-4
|
C5H4N4O1
|
|
|
Hyp 1 protein
|
|
|
|
|
Hyp 8-1 protein
|
|
|
|
|
HZF-16 protein
|
148733-47-5
|
|
|
|
Hzf protein
|
|
|
|
|
HYPREP 4601 (FOR FORMULATION)
|
|
|
|
|
HYPROMELLOSE PHTHALATE USP(CRM STANDARD)
|
|
|
|
|
HYPROMELLOSE PHTHALATE REFERENCE SPECTRUM EPH(CRM STANDARD)
|
|
|
|
|
HYPROMELLOSE (HYDROXYPROPYL METHYLCELLULOSE) USP(CRM STANDARD)
|
|
|
|
|
Hyprolose (Hydroxypropyis Cellulose)BP98
|
|
|
|
|
HYPROMELOSE PHTHALATE, NF (TYPE HP-55)
|
|
|
|
|
Hypromellose phthalate
|
|
|
|
|
HYPROXANTHINE
|
|
|
|
|
hyproprotein
|
|
|
|
|
HYPROMELLOSE
|
8063-82-9
|
|
|
|
HY5 protein
|
|
|
|
|
HYPSIZIPRENOLA9
|
|
|
|
|
HYPSIZIGUSMARMOREUS
|
|
|
|
|
HYPSIZYGUSMARMOREUS
|
|
|
|
|
hypsorhodopsin
|
|
|
|
|
HYPTIS SUAVEOLENS SEED OIL
|
|
|
|
|
hypusine
|
34994-11-1
|
C10H23N3O3
|
|
hyrcanoside
|
15001-93-1
|
C34H48O14
|
|
|
HYRCANOSIDE
|
60197-59-3
|
|
|
HYRCANOSIDE
|
|
C21H30O14
|
|
2-Hyrdoxy-4-Methyl-5-Nitropyridine
|
21091-41-7
|
C6H6N2O3
|
|
|
HypX protein
|
|
|
|
|
Hyriopsis cumingii L.Pearl powder and pearl mussel meat extract
|
|
|
|
|
Hyscine N Butyl bromide
|
|
|
|
|
Hyrnecromone
|
|
|
|
4-Hyroxy carbazole
|
|
C12H9NO
|
|
|
2-((2-(-hyroxyethyl)amino)ethyl)-10-methyl-1,2,3,10-(2,3-b)pyrrolo(3,4-e)indole-1,3-dione
|
|
|
|
|
HYR1 protein
|
|
|
|
|
HYSIMAL
|
|
|
|
|
hyrtial
|
97889-56-0
|
|
|
|
hytac
|
|
|
|
|
HYSOL BLACK BC
|
|
|
|
|
Hyspin AWS 100
|
|
|
|
|
HY SOY
|
73049-73-7
|
NULL
|
|
|
HYS2 protein
|
|
|
|
|
HYTHERM EMERALD 9
|
|
|
|
|
HYTHERM BLACK B
|
|
|
|
|
HYTHERM BLUE B
|
|
|
|
|
HYTHERM BLUE GREEN BF
|
|
|
|
|
HYTHERM BLUE E
|
|
|
|
|
HYTHERM VIOLET KIF
|
|
|
|
|
hystazarin
|
483-35-2
|
C14H6O2(OH)2
|
|
|
Hyssop, ext.
|
84603-66-7
|
|
|
|
Hyssop-HyssopusOfficinalis
|
|
|
|
|
HyssopPowder,HyssopusOfficinalis
|
|
|
|
|
Hyssop Oil
|
8006-83-5
|
|
|
|
HyssopusOfficinalis
|
|
|
|
|
HYSSOP
|
|
|
|
HYSTRINE
|
18017-50-0
|
|
|
|
HYTORAY CATALYST
|
|
|
|
|
HYUGANATSU
|
|
|
|
|
HYUGANATSUOIL
|
|
|
|
|
Hyt1 protein
|
|
|
|
|
Hytrel
|
|
|
|
|
HYTREL THERMOPLASTIC POLYESTER ELASTOMER
|
|
|
|
|
(3H)-ZM 241385
|
|
|
|
4-Hyxdroxy-2-iodo-3-methoxypyridine
|
405137-17-9
|
C6H6INO2
|
|
|
99HZZ66 [3H]
|
|
|
|
|
Hünigbase/Diidopropylethylamine
|
|
|